FR2253512B1 - - Google Patents

Info

Publication number
FR2253512B1
FR2253512B1 FR7439371A FR7439371A FR2253512B1 FR 2253512 B1 FR2253512 B1 FR 2253512B1 FR 7439371 A FR7439371 A FR 7439371A FR 7439371 A FR7439371 A FR 7439371A FR 2253512 B1 FR2253512 B1 FR 2253512B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7439371A
Other languages
French (fr)
Other versions
FR2253512A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2253512A1 publication Critical patent/FR2253512A1/fr
Application granted granted Critical
Publication of FR2253512B1 publication Critical patent/FR2253512B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
FR7439371A 1973-11-30 1974-12-02 Expired FR2253512B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
FR2253512A1 FR2253512A1 (enExample) 1975-07-04
FR2253512B1 true FR2253512B1 (enExample) 1978-02-03

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7439371A Expired FR2253512B1 (enExample) 1973-11-30 1974-12-02

Country Status (14)

Country Link
US (1) US4045574A (enExample)
JP (1) JPS5084561A (enExample)
AT (1) AT347611B (enExample)
CA (1) CA1030522A (enExample)
CH (1) CH618183A5 (enExample)
DD (1) DD115659A5 (enExample)
DK (1) DK134348C (enExample)
ES (1) ES432106A1 (enExample)
FR (1) FR2253512B1 (enExample)
GB (1) GB1494097A (enExample)
IE (1) IE40423B1 (enExample)
IL (1) IL46153A (enExample)
NL (1) NL7415577A (enExample)
SE (1) SE408426B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
BR0313523A (pt) * 2002-08-16 2005-06-28 Upjohn Co Intermediários do esteróide 5-androsten-3(beta)-ol e processos para a sua preparação
RU2019126333A (ru) 2013-04-17 2019-10-08 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
CN113527400B (zh) 2013-04-17 2024-06-28 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SMT202000414T1 (it) 2014-10-16 2020-09-10 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
MX2021004492A (es) 2014-10-16 2022-12-05 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
ME03749B (me) 2014-11-27 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
US20220315621A1 (en) * 2017-12-22 2022-10-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
IL312610B2 (en) 2018-12-05 2026-05-01 Sage Therapeutics Llc Neuroactive steroids and methods of using them
US12415830B2 (en) 2019-01-08 2025-09-16 Chengdu kanghong pharmaceutical co ltd Steroid compound, and use thereof and preparation method therefor
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物
WO2020264495A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders
TWI896547B (zh) 2019-06-27 2025-09-11 美商賽吉醫療公司 用於治療cns病症之組合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
AT347611B (de) 1979-01-10
ATA950774A (de) 1978-05-15
SE408426B (sv) 1979-06-11
SE7414960L (enExample) 1975-06-02
DD115659A5 (enExample) 1975-10-12
NL7415577A (nl) 1975-06-03
DK134348C (da) 1977-03-21
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
CA1030522A (en) 1978-05-02
FR2253512A1 (enExample) 1975-07-04
IL46153A (en) 1979-01-31
DK604174A (enExample) 1975-07-28
CH618183A5 (enExample) 1980-07-15
US4045574A (en) 1977-08-30
AU7586774A (en) 1976-06-03
DK134348B (da) 1976-10-25
IL46153A0 (en) 1975-02-10
IE40423B1 (en) 1979-05-23
JPS5084561A (enExample) 1975-07-08
GB1494097A (en) 1977-12-07

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
FR2253512A1 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU466283B2 (enExample)
AR199451A1 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AU477823B2 (enExample)
AR195948A1 (enExample)
AR197627A1 (enExample)
AR200885A1 (enExample)
AR200256A1 (enExample)
AR193950A1 (enExample)
AU477824B2 (enExample)
AR210729A1 (enExample)
AU476873B1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse